Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 1977. Start Trial.
Date Value
November 20, 2026 224.76
November 19, 2026 223.00
November 18, 2026 227.66
November 17, 2026 234.50
November 16, 2026 240.54
November 13, 2026 242.45
November 12, 2026 238.21
November 11, 2026 240.47
November 10, 2026 240.05
November 09, 2026 237.52
November 06, 2026 237.52
November 05, 2026 241.31
November 04, 2026 245.36
November 03, 2026 235.88
November 02, 2026 240.89
October 30, 2026 238.82
October 29, 2026 234.66
October 28, 2026 231.52
October 27, 2026 235.27
October 26, 2026 235.50
October 23, 2026 235.00
October 22, 2026 240.81
October 21, 2026 233.62
October 20, 2026 235.77
October 19, 2026 224.87
Date Value
October 16, 2026 228.39
October 15, 2026 231.52
October 14, 2026 226.59
October 13, 2026 216.62
October 12, 2026 220.09
October 09, 2026 225.98
October 08, 2026 227.74
October 07, 2026 228.20
October 06, 2026 227.78
October 05, 2026 224.80
October 02, 2026 233.74
October 01, 2026 232.53
September 30, 2026 236.09
September 29, 2026 237.83
September 28, 2026 241.68
September 25, 2026 237.83
September 24, 2026 232.68
September 23, 2026 231.36
September 22, 2026 235.52
September 21, 2026 236.92
September 18, 2026 238.58
September 17, 2026 237.75
September 16, 2026 240.63
September 15, 2026 241.12
September 14, 2026 242.52

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Johnson & Johnson 645.40
Eli Lilly & Co. 3563.61
Merck & Co., Inc. 413.52
Pfizer Inc. 92.99
AstraZeneca PLC 440.08